DUBLIN--(BUSINESS WIRE)--Sep 3, 2020--

The report provides comprehensive insights into Psoriatic Arthritis pipeline products, Psoriatic Arthritis epidemiology, Psoriatic Arthritis market valuations and forecast, Psoriatic Arthritis drugs sales and competitive landscape in the US.

The research is classified into seven sections - Psoriatic Arthritis treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope

  • Psoriatic Arthritis pipeline: Find out the products in clinical trials for the treatment of Psoriatic Arthritis by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Psoriatic Arthritis epidemiology: Find out the number of patients diagnosed (prevalence) with Psoriatic Arthritis in the US
  • Psoriatic Arthritis drugs: Identify key products marketed and prescribed for Psoriatic Arthritis in the US, including trade name, molecule name, and company
  • Psoriatic Arthritis drugs sales: Find out the sales revenues of Psoriatic Arthritis drugs in the US
  • Psoriatic Arthritis market valuations: Find out the market size for Psoriatic Arthritis drugs in 2019 in the US. Find out how the market advanced from 2016 and forecast to 2025
  • Psoriatic Arthritis drugs market share: Find out the market shares for key Psoriatic Arthritis drugs in the US

Benefits of this Research

  • Support monitoring and reporting national Psoriatic Arthritis market analysis and sales trends
  • Track competitor drugs sales and market share in the US Psoriatic Arthritis market
  • Track competitive developments in Psoriatic Arthritis market and present key issues and learnings
  • Synthesize insights for Psoriatic Arthritis market and products to drive business performance
  • Answer key business questions about the Psoriatic Arthritis market
  • Evaluate commercial market opportunity assessment, positioning, and segmentation for Psoriatic Arthritis products
  • Supports decision making in R&D to long term marketing strategies

Key Topics Covered

1) Psoriatic Arthritis Treatments

2) Psoriatic Arthritis Pipeline

3) US Psoriatic Arthritis Epidemiology

4) Marketed Drugs for Psoriatic Arthritis in US

5) US Psoriatic Arthritis Market Size and Forecast

6) US Psoriatic Arthritis Products Sales and Forecast

7) US Psoriatic Arthritis Market Competitive Landscape

8) Methodology

List of Tables

1. Psoriatic Arthritis Phase 3 Clinical Trials, 2020

2. Psoriatic Arthritis Phase 2 Clinical Trials, 2020

3. Psoriatic Arthritis Phase 1 Clinical Trials, 2020

4. Psoriatic Arthritis Epidemiology, US, 2016 - 2025

5. Marketed Drugs for Psoriatic Arthritis, US, 2019

6. Psoriatic Arthritis Market Size and Forecast ($), US, 2016 - 2025

7. Psoriatic Arthritis Product Sales ($), US, 2016 - 2025

List of Figures

1. Psoriatic Arthritis Epidemiology, US, 2016 - 2025

2. Psoriatic Arthritis Market Size and Forecast ($), US, 2016 - 2025

3. Psoriatic Arthritis Products Market Share (%), US, 2019

For more information about this report visit https://www.researchandmarkets.com/r/dfiqyu

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: PHARMACEUTICAL HEALTH CLINICAL TRIALS

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 09/03/2020 06:49 AM/DISC: 09/03/2020 06:49 AM

Copyright Business Wire 2020.